Abstract
Olanzapine, an atypical antipsychotic drug, was administered to a patient with Huntington's disease (HD) with marked choreiform movements. Brain SPECT with 99mTc-HMPAO was performed before and after treatment. Brain SPECT imaging has been performed in patients with HD in order to determine the status of basal ganglia perfusion. The use of brain SPECT with 99mTc-HMPAO before and after treatment in patients with HD has not been yet reported. The marked hypoperfusion of the basal ganglia on brain SPECT performed before therapy with olanzapine improved significantly after treatment.
Author supplied keywords
Cite
CITATION STYLE
Etchebehere, E. C. S. C., Lima, M. C. L., Passos, W., Maciel, J. A., Santos, A. O., Ramos, C. D., & Camargo, E. E. (1999). Brain SPECT imaging in Huntington’s disease before and after therapy with olanzapine: Case report. Arquivos de Neuro-Psiquiatria, 57(3 B), 863–866. https://doi.org/10.1590/S0004-282X1999000500021
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
